Panels by Tissue Type

ATCC has designed tumor cell panels based on the tissue of tumor origin, each annotated with details regarding known mutations - enabling more intelligent choices when selecting cell-based research models.
Bladder

Bladder Cancer Cell Panels

Bladder tumor cell lines containing mutations in one or more of the following genes: PIK3CA, RB1, RAS, TSC1, CDKN2A, PTEN, and TP53
Osteocyte bone

Bone Cancer Cell Panels

Bone cancer cell lines containing mutations in one or more of the following genes: CDKN2A, BRAF, TP53, RB1, and PTEN.
B0004607 Credit University of Edinburgh, Wellcome Images  pituitary.jpg

Brain Cancer Cell Panels

ATCC has developed two brain cancer cell line panels with varying degrees of genetic complexity, including mutations in TP53 and PTEN.
Human Breast Cancer cell dividing

Breast Cancer Cell Panels

The ATCC Breast Cancer Cell Panel reflects important genomic abnormalities found in primary breast tumors, which may reveal how they contribute to breast cancer pathologies.
Human colon cancer cells

Colon Cancer Cell Panels

ATCC has developed two colon cancer panels with varying degrees of genetic complexity, and organized by BRAF or KRAS mutations.
mouse ovary

Ovarian Cancer Cell Panels

Ovarian cancer cell lines with varying degrees of genetic complexity, including mutations in APC, FAM123B, RAS, MLH1, PIK3, STK11, and TP53
skin cancer cell 2.jpg

Head/Neck Cancer Cell Panels

The head and neck cancer cell panel represents cultures with varying degrees of genetic complexity, isolated from salivary gland, tongue, hypopharynx and pharynx.
Leukemia

Leukemia Cell Panels

The leukemia cancer cell panel represents a diverse collection of Acute Myeloid (AML), Acute Monocytic (AMoL), Chronic Myeloid (CML), and Acute Lymphoblastic (ALL) Leukemia.
Lymphocyte

Lymphoma Cell Panels

In an effort to aid biomarker and novel therapeutic discovery, as well as the development of early detection methods that are rapid and accurate, ATCC has assembled lymphoma cell panels to accelerate new discoveries in lymphoma research.

hepatocyte

Liver Cancer Cell Panels

ATCC has developed a liver cancer cell panel from cultures displaying varying degrees of genetic complexity, including mutations in BRAF, CTNNB1, and STK11
Lung cancer cell

Lung Cancer Cell Panels

Lung cancer cell lines with varying degrees of genetic complexity, including mutations in EGFR, RAS, PIK3, and TP53.
Human melanoma cell dividing.jpg

Melanoma Cancer Cell Panels

ATCC has developed 2 melanoma cancer cell panels with varying degrees of genetic complexity, representing both primary and metastatic tumors.
DNA strand

Molecular Signature Panels

ATCC has designed a set of cell panels to help investigators examine the genetic and functional abnormalities of cell signaling pathway components responsible for cancer, autoimmunity, diabetes and many other diseases.

Pancreatic cancer cells.jpg

Pancreatic Cancer Cell Panels

Pancreatic cancer cell lines with varying degrees of genetic complexity, including mutations in FBXW7, RAS, MAP2K4, SMAD4, and TP53.
human cancer cells polarized light micrograph of 3w3402

Soft-Tissue Sarcoma Cell Panels

A virtual panel of 6 soft-tissue tumor cell lines with varying degrees of genetic complexity. Each culture contains genomic mutations in one or more of the following genes according to the Sanger COSMIC database: CDKN2A, IDH1, NRAS, BRAF, PTEN, and TP53.

Human colon cancer cells.jpg

Stomach Cancer Cell Panels

ATCC has organized a panel of stomach cancer cell lines isolated from both primary and metastatic sites, including mutations in TP53, SMAD4, CDH1, and CTNNB1.